2023年9月12日 · Notably, the Health Care Select Sector SPDR Fund (NYSEARCA:XLV) holds the distinction of being the largest pharma ETF, featuring many prominent pharmaceutical industry names.

ETF issuers who have ETFs with exposure to Pharmaceutical are ranked on certain investment-related metrics, including estimated revenue, 3-month fund flows, 3-month return, AUM, average ETF expenses and average dividend yields. The metric calculations are based on U.S.-listed Pharmaceutical ETFs and every Pharmaceutical ETF has one issuer.

2022年9月20日 · The pharmaceutical exchange-traded funds (ETFs) with the best one-year trailing total returns are PPH, IHE, and PJP. The top holdings of these ETFs are Mckesson Corp., Johnson & Johnson, and...

4 天之前 · The iShares U.S. Pharmaceuticals ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector.

2024年11月5日 · To help investors learn more about ETFs focused on the pharma sector, the Investing News Network presents the five top pharma ETFs by total assets under management, according to ETFdb.com.

See the best pharmaceutical ETFs of 2023 ranked by performance and get a market outlook for big pharma stocks in 2024.

Pharma ETFs provide a convenient way to gain exposure to industry leaders and innovative newcomers in the pharmaceutical space. With a strong 2025 outlook driven by companies like Eli Lilly, Pfizer, and Sanofi, now is the time to explore these opportunities.

3 天之前 · Learn more about Pharmaceuticals ETFs including comprehensive lists, performance, dividends, holdings, expense ratios, technicals and daily news.

2024年8月6日 · Best pharmaceuticals ETF iShares U.S. Pharmaceuticals ETF (IHE) This ETF tracks an index of U.S.-listed pharmaceutical companies, and it includes the stocks of Eli Lilly, Johnson &...

2023年9月12日 · We have shortlisted the 12 best pharma ETFs based on their historical five-year performance as of September 11. The best pharma ETFs also provide exposure to industries like biotechnology, clinical trials, and immunotherapy. The ETFs have been ranked in ascending order of their 5-year performance. 12. iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)